EUVIMEDEUVIMED entdecken
Open Access

Efficacy and safety of GH treatment in Japanese pediatric patients with SHOX deficiency: an open-label extension study

Tsutomu Ogata, Sumito Dateki, Maki Fukami, Naoko Takasao, Hideaki Hirai, Ryo Ibaraki, Osamu Yoshida, Tatsuyoshi Yamamoto

Clinical Pediatric Endocrinology · 2026 · 35 (3) · 246-254

DOI: 10.1297/cpe.2025-0122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pediatric Endocrinology, 2026. Verfasst von Tsutomu Ogata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pediatrics and Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JCR Pharmaceuticals Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

SHOXefficacygrowth hormonesafetyshort stature

Autor:innen und Institutionen

  • Departments of Pediatrics and Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Pediatrics, Hamamatsu Medical Center, Hamamatsu, Japan.
  • Department of Pediatrics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
  • Japan Development Unit, JCR Pharmaceuticals Co., Ltd., Ashiya, Japan.
  • Development Division, JCR Pharmaceuticals Co., Ltd., Ashiya, Japan.

Förderung

  • JCR Pharmaceuticals Co., Ltd.

Zitieren

APA

Ogata, T., Dateki, S., Fukami, M., Takasao, N., Hirai, H., Ibaraki, R., Yoshida, O., & Yamamoto, T. (2026). Efficacy and safety of GH treatment in Japanese pediatric patients with SHOX deficiency: an open-label extension study. Clinical Pediatric Endocrinology, 35(3), 246-254. https://doi.org/10.1297/cpe.2025-0122

Vancouver

Ogata T, Dateki S, Fukami M, Takasao N, Hirai H, Ibaraki R, et al. Efficacy and safety of GH treatment in Japanese pediatric patients with SHOX deficiency: an open-label extension study. Clinical Pediatric Endocrinology. 2026;35(3):246-254. doi:10.1297/cpe.2025-0122

BibTeX
@article{Ogata2026,
  author = {Ogata, Tsutomu and Dateki, Sumito and Fukami, Maki and Takasao, Naoko and Hirai, Hideaki and Ibaraki, Ryo and Yoshida, Osamu and Yamamoto, Tatsuyoshi},
  title = {Efficacy and safety of GH treatment in Japanese pediatric patients with SHOX deficiency: an open-label extension study},
  journal = {Clinical Pediatric Endocrinology},
  year = {2026},
  volume = {35},
  number = {3},
  pages = {246--254},
  doi = {10.1297/cpe.2025-0122}
}
Kostenlos starten →